Caribou Bio Grants IDT Non-Exclusive Rights to Commercialize RUO CRISPR/Cas9 Reagents

GenomeWeb 23 February 2016 https://www.genomeweb.com/gene-silencinggene-editing/caribou-bio-grants-idt-non-exclusive-rights-commercialize-ruo-crisprcas9

Caribou Biosciences, co-founded by Jennifer Doudna of the University of California-Berkley, has granted a non-exclusive license to Integrated DNA Technologies (IDT) to develop and sell CRISPR/Cas9 products for research use only.  Caribou has also licensed the technology to DuPont Pioneer, Sage Labs, and Novartis, however IDT is the first genomics company to obtain a license.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply